We now show that NT induces release of extracellular mitochondrial DNA (mtDNA ... p = 0.006), and anti-mitochondrial antibody Type 2 (n = 14; p = 0.001) as compared to normally developing ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

Baylor College of Medicine, Houston, TX.

2025年的ASCO年会将于5月30日-6月3日在美国芝加哥举行。中山大学肿瘤防治中心以卓越的创新实力再创佳绩，共有14项重磅研究入选本届年会，覆盖肺部肿瘤、头颈肿瘤、血液恶性肿瘤、中枢神经系统肿瘤等领域，涉及创新治疗策略、分子靶向及生物疗法等。其中 ...

QuantX Biosciences Limited, Princeton, NJ.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

Seven oral presentations will unveil novel immunotherapy insights, including IBI363, at one of oncology’s biggest global ...

University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of ...

Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...